ECGFF yields 1000.00% · PFE yields 6.13%● Live data
📍 ECGFF pulled ahead of the other in Year 1
Combined, ECGFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ECGFF + PFE for your $10,000?
EcoGraf Limited engages in building a diversified battery anode material business that produces graphite products for the clean energy and lithium-ion battery markets in Asia, Europe, and North America. It develops HFfree purification technology, which produces battery anode material to support electric vehicle, battery, and anode manufacturers. The company also provides EcoGraf purification process that enables battery supply chain customers to reduce their CO2 emissions and lower battery costs. In addition, it is involved in the developing of TanzGraphite natural flake graphite business through its Epanko Graphite Project in Tanzania, which offers flake graphite products for industrial applications. The company was formerly known as Kibaran Resources Limited and changed its name to EcoGraf Limited in December 2019. EcoGraf Limited was incorporated in 2005 and is headquartered in West Perth, Australia.
Full ECGFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.